What is NovoCure's inventories?

NovoCure (NVCR) reported inventories of $43.46M in Q1 2026.

How has NovoCure's inventories changed year-over-year?

NovoCure's inventories increased by 10.1% year-over-year, from $39.47M to $43.46M.

What is the long-term trend for NovoCure's inventories?

Over 5 years (2020 to 2025), NovoCure's inventories has grown at a 8.4% compound annual growth rate (CAGR), from $27.42M to $41.11M.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

NovoCure NVCR Inventories

Inventories at other companies

Boston ScientificBSX

$3.12B+8.7%

MedtronicMDT

$5.95B+8.7%

Iovance Biotherapeutics, Inc.IOVA

$58.38M-10.9%

Nuvation BioNUVB

$15.84M+113,071%

Syndax PharmaceuticalsSNDX

$34.95M+649%

ALN

Alnylam PharmaceuticalsALNY

$84.03M+28.1%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's inventories?: NovoCure (NVCR) reported inventories of $43.46M in Q1 2026.
How has NovoCure's inventories changed year-over-year?: NovoCure's inventories increased by 10.1% year-over-year, from $39.47M to $43.46M.
What is the long-term trend for NovoCure's inventories?: Over 5 years (2020 to 2025), NovoCure's inventories has grown at a 8.4% compound annual growth rate (CAGR), from $27.42M to $41.11M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.